The modified radical mastectomy of Patey: technique and experience.
Identifieur interne : 004F53 ( PubMed/Checkpoint ); précédent : 004F52; suivant : 004F54The modified radical mastectomy of Patey: technique and experience.
Auteurs : M D Staunton [Royaume-Uni] ; D M Melville ; A. Monterrosa ; J. ThomasSource :
- Annals of the Academy of Medicine, Singapore [ 0304-4602 ] ; 1993.
Descripteurs français
- KwdFr :
- Association thérapeutique, Femelle, Humains, Lymphadénectomie, Mastectomie radicale modifiée (), Mastectomie radicale modifiée (effets indésirables), Pronostic, Récidive tumorale locale (épidémiologie), Tamoxifène (usage thérapeutique), Taux de survie, Traitement médicamenteux adjuvant, Tumeurs du sein (), Tumeurs du sein (mortalité), Tumeurs du sein (radiothérapie), Tumeurs du sein (traitement médicamenteux), Études de suivi.
- MESH :
- effets indésirables : Mastectomie radicale modifiée.
- mortalité : Tumeurs du sein.
- radiothérapie : Tumeurs du sein.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Tamoxifène.
- épidémiologie : Récidive tumorale locale.
- Association thérapeutique, Femelle, Humains, Lymphadénectomie, Mastectomie radicale modifiée, Pronostic, Taux de survie, Traitement médicamenteux adjuvant, Tumeurs du sein, Études de suivi.
English descriptors
- KwdEn :
- Breast Neoplasms (drug therapy), Breast Neoplasms (mortality), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Chemotherapy, Adjuvant, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymph Node Excision, Mastectomy, Modified Radical (adverse effects), Mastectomy, Modified Radical (methods), Neoplasm Recurrence, Local (epidemiology), Prognosis, Survival Rate, Tamoxifen (therapeutic use).
- MESH :
- chemical , therapeutic use : Tamoxifen.
- adverse effects : Mastectomy, Modified Radical.
- drug therapy : Breast Neoplasms.
- epidemiology : Neoplasm Recurrence, Local.
- methods : Mastectomy, Modified Radical.
- mortality : Breast Neoplasms.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Chemotherapy, Adjuvant, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymph Node Excision, Prognosis, Survival Rate.
Abstract
We report our experience from 193 patients with breast cancer treated by Modified Radical Mastectomy of Patey and describe the technique used, amplified by illustrations. We achieved a low morbidity viz symptomatic lymphoedema five cases, chronic shoulder stiffness one case, skin grafting two cases, and all cases of chest wall pain cleared by four years. Cancer recurred, to date, local in nine cases (4.6%), local and systemic in 17 cases (8.9%) and systemic in 27 cases (13.9%). We compile, for the first time, all references by Patey and Richard Handley to the procedure. We recommend the operation as achieving complete primary clearance with safe and full axillary node removal. Histological state of the nodes allows rational decisions on adjuvant therapy with hormones and chemotherapy.
PubMed: 8363339
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:8363339Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The modified radical mastectomy of Patey: technique and experience.</title><author><name sortKey="Staunton, M D" sort="Staunton, M D" uniqKey="Staunton M" first="M D" last="Staunton">M D Staunton</name><affiliation wicri:level="3"><nlm:affiliation>St Bartholomew's Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>St Bartholomew's Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Melville, D M" sort="Melville, D M" uniqKey="Melville D" first="D M" last="Melville">D M Melville</name></author><author><name sortKey="Monterrosa, A" sort="Monterrosa, A" uniqKey="Monterrosa A" first="A" last="Monterrosa">A. Monterrosa</name></author><author><name sortKey="Thomas, J" sort="Thomas, J" uniqKey="Thomas J" first="J" last="Thomas">J. Thomas</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1993">1993</date><idno type="RBID">pubmed:8363339</idno><idno type="pmid">8363339</idno><idno type="wicri:Area/PubMed/Corpus">005770</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005770</idno><idno type="wicri:Area/PubMed/Curation">005770</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005770</idno><idno type="wicri:Area/PubMed/Checkpoint">005770</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005770</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The modified radical mastectomy of Patey: technique and experience.</title><author><name sortKey="Staunton, M D" sort="Staunton, M D" uniqKey="Staunton M" first="M D" last="Staunton">M D Staunton</name><affiliation wicri:level="3"><nlm:affiliation>St Bartholomew's Hospital, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>St Bartholomew's Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Melville, D M" sort="Melville, D M" uniqKey="Melville D" first="D M" last="Melville">D M Melville</name></author><author><name sortKey="Monterrosa, A" sort="Monterrosa, A" uniqKey="Monterrosa A" first="A" last="Monterrosa">A. Monterrosa</name></author><author><name sortKey="Thomas, J" sort="Thomas, J" uniqKey="Thomas J" first="J" last="Thomas">J. Thomas</name></author></analytic><series><title level="j">Annals of the Academy of Medicine, Singapore</title><idno type="ISSN">0304-4602</idno><imprint><date when="1993" type="published">1993</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (mortality)</term><term>Breast Neoplasms (radiotherapy)</term><term>Breast Neoplasms (surgery)</term><term>Chemotherapy, Adjuvant</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Mastectomy, Modified Radical (adverse effects)</term><term>Mastectomy, Modified Radical (methods)</term><term>Neoplasm Recurrence, Local (epidemiology)</term><term>Prognosis</term><term>Survival Rate</term><term>Tamoxifen (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Mastectomie radicale modifiée ()</term><term>Mastectomie radicale modifiée (effets indésirables)</term><term>Pronostic</term><term>Récidive tumorale locale (épidémiologie)</term><term>Tamoxifène (usage thérapeutique)</term><term>Taux de survie</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (mortalité)</term><term>Tumeurs du sein (radiothérapie)</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Tamoxifen</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Mastectomy, Modified Radical</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Mastectomie radicale modifiée</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mastectomy, Modified Radical</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Tamoxifène</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Récidive tumorale locale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Chemotherapy, Adjuvant</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Prognosis</term><term>Survival Rate</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Mastectomie radicale modifiée</term><term>Pronostic</term><term>Taux de survie</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs du sein</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report our experience from 193 patients with breast cancer treated by Modified Radical Mastectomy of Patey and describe the technique used, amplified by illustrations. We achieved a low morbidity viz symptomatic lymphoedema five cases, chronic shoulder stiffness one case, skin grafting two cases, and all cases of chest wall pain cleared by four years. Cancer recurred, to date, local in nine cases (4.6%), local and systemic in 17 cases (8.9%) and systemic in 27 cases (13.9%). We compile, for the first time, all references by Patey and Richard Handley to the procedure. We recommend the operation as achieving complete primary clearance with safe and full axillary node removal. Histological state of the nodes allows rational decisions on adjuvant therapy with hormones and chemotherapy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8363339</PMID><DateCreated><Year>1993</Year><Month>09</Month><Day>30</Day></DateCreated><DateCompleted><Year>1993</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0304-4602</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>2</Issue><PubDate><Year>1993</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Annals of the Academy of Medicine, Singapore</Title><ISOAbbreviation>Ann. Acad. Med. Singap.</ISOAbbreviation></Journal><ArticleTitle>The modified radical mastectomy of Patey: technique and experience.</ArticleTitle><Pagination><MedlinePgn>233-6</MedlinePgn></Pagination><Abstract><AbstractText>We report our experience from 193 patients with breast cancer treated by Modified Radical Mastectomy of Patey and describe the technique used, amplified by illustrations. We achieved a low morbidity viz symptomatic lymphoedema five cases, chronic shoulder stiffness one case, skin grafting two cases, and all cases of chest wall pain cleared by four years. Cancer recurred, to date, local in nine cases (4.6%), local and systemic in 17 cases (8.9%) and systemic in 27 cases (13.9%). We compile, for the first time, all references by Patey and Richard Handley to the procedure. We recommend the operation as achieving complete primary clearance with safe and full axillary node removal. Histological state of the nodes allows rational decisions on adjuvant therapy with hormones and chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Staunton</LastName><ForeName>M D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>St Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melville</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Monterrosa</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Ann Acad Med Singapore</MedlineTA><NlmUniqueID>7503289</NlmUniqueID><ISSNLinking>0304-4602</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>094ZI81Y45</RegistryNumber><NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015411" MajorTopicYN="N">Mastectomy, Modified Radical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013629" MajorTopicYN="N">Tamoxifen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8363339</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><noCountry><name sortKey="Melville, D M" sort="Melville, D M" uniqKey="Melville D" first="D M" last="Melville">D M Melville</name><name sortKey="Monterrosa, A" sort="Monterrosa, A" uniqKey="Monterrosa A" first="A" last="Monterrosa">A. Monterrosa</name><name sortKey="Thomas, J" sort="Thomas, J" uniqKey="Thomas J" first="J" last="Thomas">J. Thomas</name></noCountry><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Staunton, M D" sort="Staunton, M D" uniqKey="Staunton M" first="M D" last="Staunton">M D Staunton</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004F53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:8363339
|texte= The modified radical mastectomy of Patey: technique and experience.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:8363339" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |